Silo Wellness Inc.

Equities

SILO

CA8271242072

Pharmaceuticals

Delayed Canadian Securities Exchange 03:44:08 2023-08-28 pm EDT 5-day change 1st Jan Change
0.01 CAD +100.00% Intraday chart for Silo Wellness Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI
Silo Wellness Inc. announced that it expects to receive CAD 2 million in funding CI
Silo Wellness Inc. enter into a letter of intent to acquire NUGL Inc. for CAD 40.2 million. CI
Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats CI
Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023 CI
Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt CI
Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023 CI
Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2022 CI
Michael Hartman entered into a definitive stock purchase agreement to acquire SW Holdings, Inc. from Silo Wellness Inc. for CAD 0.21 million. CI
Silo Wellness Inc. Announces Resignation of Gerard Lee from as A Director of the Board CI
Silo Wellness Inc. Executes Binding Term Sheet for A Joint Venture with New Frontier Ranch CI
Silo Wellness Inc. completed the acquisition of Dyscovry Science Ltd. CI
Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022 CI
384,082 Common Shares of Yukoterre Resources Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2022. CI
Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022 CI
Silo Wellness Inc. Announces Change of Chief Executive Officer CI
Silo Wellness Inc. executed a nonbinding letter of intent to acquire Dyscovry Science Ltd. CI
Silo Wellness Inc. announced that it expects to receive CAD 5.95 million in funding from Alpha Blue Ocean Investment Group CI
Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022 CI
384,081 Common Shares of Yukoterre Resources Inc. are subject to a Lock-Up Agreement Ending on 24-MAR-2022. CI
Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2021 CI
Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt CI
Silo Wellness Inc. announced that it expects to receive $0.494988 million in funding from Orthogonal Thinker, Inc., Investment Arm CI
Silo Wellness Signs Distribution Deal with Flawless CBD for Functional Mushroom Products CI
Silo Wellness Inc. Announces Board Changes CI
Chart Silo Wellness Inc.
More charts
Silo Wellness, Inc. is a Canada-based global psychedelics company. The Company is engaged in psilocybin wellness retreats. The Company operates through the Jamaica retreats segment. The Company offers psychedelic wellness retreats in Jamaica and is focused on doing the same in Oregon, United States. The Company also maintains rights in intellectual property (IP). In addition to its IP portfolio, The Company is focusing on consumer product and wellness retreat brand development for psychedelics. It is focusing on improving health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance, by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.
More about the company
  1. Stock Market
  2. Equities
  3. SILO Stock
  4. News Silo Wellness Inc.
  5. Silo Wellness : Names UK Distributor of Psychedelic Mushroom Portfolio
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW